Products
Emmaus Medical, Inc. Science & technology
NutreStore™ (L-glutamine powder for oral solution) is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support when used in conjunction with Zorbtive® [somatropin (rDNA origin) for injection].  

Important Safety Considerations:
The symptoms experienced while taking NutreStore™ may be due to SBS or may be side effects of NutreStore™ and/or Zorbtive®.  Reported side effects of NutreStore™ included the urge to empty bowels, gas, abdominal pain, vomiting and hemorrhoids.

Visit www.nutrestore.com for more information.

This information is not intended to replace discussions with your healthcare professional.  Please read the NutreStore™ Patient Information Leaflet and NutreStore™ Full Prescribing Information and talk to your doctor.  NutreStore™ is available by prescription only.

Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, fluid and micronutrient supplements, as needed.

Important Safety Considerations:
Some common side effects of Zorbtive® treatment include muscle and joint pain, and fluid retention (swelling). Zorbtive® may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure in the brain. Growth hormone therapy should not be initiated in patients with acute critical illness due to complications following open heart or abdominal surgery, multiple accidental trauma or acute respiratory failure. Zorbtive® is contraindicated in the presence of active neoplasia (either newly diagnosed or recurrent). Any anti-tumor therapy should be completed prior to starting therapy with Zorbtive®. Zorbtive® is reconstituted with Bacteriostatic Water for Injection, USP (0.9% Benzyl Alcohol) should not be administered to patients with a known sensitivity to Benzyl Alcohol.

Visit www.Zorbtive.com for more information.

This information is not intended to replace discussions with your healthcare professional. Please read the Zorbtive® Patient Information Leaflet and Zorbtive® Full Prescribing Information and talk to your doctor. You can also call SeroCare℠ toll free at 800-714-2437.

Zorbtive® is available by prescription only. Zorbtive® and NutreStore™ are marketed in the U.S. by Emmaus Medical, Inc.

Disclaimer. This site contains medical information that is intended for residents of the United States only and is not meant to be a substitute for the advice provided by a medical professional. Always consult a healthcare provider if you have health concerns.

bottom_selections

Home I Coporate Overview I Science and Technology I News I Contact Us I Careers
Privacy I Terms of Use I Sitemap

Emmaus Medical, Inc. Trademark ™ Emmaus Medical, Inc, Torrance, CA. All rights reserved.
All materials (text, images, illustrations) contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of Emmaus Medical, Inc.

Web Development By:: Axiom Graphic Design Studios- www.graphicsbyaxiom.com